Even when guideline-based preventive measures are implemented and traditional risk factors are addressed, a significant risk of CVD events persists. This is known as residual risk.

Hosted live during Heart Week on 3 May 2023, this webinar explores the latest evidence-based best practice approaches for managing residual cardiovascular risk, including novel biomarkers, predictors and treatment for residual risk.

Chaired by Professor Garry Jennings and joined by Professor Sandosh Padmanabhan along with leading Australian leading experts, the webinar covers:
- Current guideline-based management strategies for CVD risk reduction, including BP, lipids, diabetes medicines and antiplatelets
- Lipid subfractions, such as Lp(a) and their use in clinical practice for risk identification and update on emerging treatments
- Key genetic determinants of CVD and how polygenic risk can be utilised to enhance traditional screening strategies
- Inflammatory, thrombotic and diabetes considerations for residual CVD risk
- A case study illustrating the practical application of approaches to managing residual risk in primary care.

For practical CVD risk assessment and management templates and resources, visit the Heart Health Check Toolkit - [ Ссылка ]

свернуть